Calumet Specialty Products Partners (NASDAQ:CLMT) Given “Buy” Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Calumet Specialty Products Partners (NASDAQ:CLMTFree Report) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $33.00 price target on the oil and gas company’s stock.

CLMT has been the topic of several other research reports. TD Cowen cut their target price on Calumet Specialty Products Partners from $27.00 to $26.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. UBS Group downgraded Calumet Specialty Products Partners from a “neutral” rating to a “sell” rating and dropped their price target for the stock from $20.50 to $15.00 in a research note on Tuesday, February 4th. Wells Fargo & Company boosted their price objective on Calumet Specialty Products Partners from $25.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Finally, StockNews.com raised Calumet Specialty Products Partners to a “sell” rating in a report on Monday, November 18th. Two investment analysts have rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $23.60.

Read Our Latest Stock Analysis on CLMT

Calumet Specialty Products Partners Stock Performance

Shares of NASDAQ CLMT opened at $17.41 on Wednesday. The stock’s 50-day moving average is $19.48 and its two-hundred day moving average is $18.99. Calumet Specialty Products Partners has a 1-year low of $9.97 and a 1-year high of $25.29.

Insider Buying and Selling

In other Calumet Specialty Products Partners news, Director Jennifer Straumins sold 37,861 shares of the stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $21.42, for a total value of $810,982.62. Following the completion of the transaction, the director now directly owns 1,184,589 shares of the company’s stock, valued at approximately $25,373,896.38. This trade represents a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.91% of the stock is currently owned by corporate insiders.

About Calumet Specialty Products Partners

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Further Reading

Analyst Recommendations for Calumet Specialty Products Partners (NASDAQ:CLMT)

Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.